The U.S. and Canadian dollars are always in a battle for dominance on the global exchange market. This same competitive atmosphere is also apparent in the magic mushroom industry. The number of online magic mushroom dispensaries in Vancouver and other cities is on the rise. But, can they keep up with the rapid growth of the psychedelic sector in America? Let’s delve into this.
[toc]
Important Highlights:
- Oregon was the first state to legalize its therapeutic usage, with certified practitioners administering it.
- In 2020, the Canadian Health Minister granted four terminally ill cancer patients the right to use magic mushrooms as part of their palliative care.
- Clairvoyant is a 24-week Phase 2 trial at the University of British Columbia that is studying psilocybin-assisted therapy for adults diagnosed with alcohol abuse disorder.
The Fast-Paced Growth of the Magic Mushroom Industry in the United States.
The U.S. has witnessed a rapid growth of the magic mushroom industry, making it the only drug that competes with cannabis. This fast-paced growth signifies an increasing societal acceptance of the potential therapeutic use of this substance.
Emphasizing Mental Health
Health experts are fascinated by its potential to alleviate symptoms of mental health conditions, from depression and anxiety to PTSD. Research has yielded promising results, leading to an increased interest from private pharmaceutical companies to explore its medicinal uses.
This trend has not only sparked interest in medical applications but also significantly boosted the economy. Startups and research initiatives are focusing on the development of psilocybin.
There is increasing clinical proof supporting the use of magic mushrooms in treating specific health conditions. NIDA Director Nora Volkow has emphasized the growing evidence that psychedelics have a “substantial potential” for medical treatments.
Legal Milestones
- Oregon Measure 109: In 2020, Oregon set a precedent by being the first state to legalize psilocybin for therapeutic use, permitting professionals who are licensed to administer controlled doses. This pivotal ruling established a model for other states to emulate.
